GENVEC INC | 0,541 Euro | +0,037 +7,34 % | |
| WKN: A1H9WE ISIN: US37246C3079 Ticker-Symbol: GVC1 | Frankfurt | 21.05.13 | 08:01 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 22.03. | GenVec Q4 Net Loss Deepens | 17 | Motley Fool | |
| 22.03. | GenVec CEO Discusses Q4 2012 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 22.03. | GenVec Reports Fourth Quarter And 2012 Year-End Financial Results | 48 | PR Newswire | |
| GAITHERSBURG, Md., March 22, 2013 /PRNewswire/ --Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the fourth quarter and year ended December 31, 2012. For the year ended December... Mehr lesen zu: GenVec Reports Fourth Quarter And 2012 Year-End Financial Results | ||||
| 15.03. | GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013 | 24 | PR Newswire | |
| GAITHERSBURG, Md., March 15, 2013 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) will report financial results for the fourth quarter and year ended December 31, 2012 on Friday, March 22, 2013, before... Mehr lesen zu: GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013 | ||||
| 12.03. | GenVec to Present at 25th Annual ROTH Conference | 28 | PR Newswire | |
| GAITHERSBURG, Md., March 12, 2013 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC) announced today that Cindy Collins, GenVec's President and CEO, will present a Company overview highlighting recent developments... Mehr lesen zu: GenVec to Present at 25th Annual ROTH Conference | ||||
| 11.02. | GenVec President & CEO Cynthia Collins Joins BioHealth Innovation, Inc. Board of Directors | 45 | PR Newswire | |
| ROCKVILLE, Md., Feb. 11, 2013 /PRNewswire/ --BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing... Mehr lesen zu: GenVec President & CEO Cynthia Collins Joins BioHealth Innovation, Inc. Board of Directors | ||||
| 17.12. | Single Administration of GenVec's Vaccine Provides Protective Immunity Against HSV in Pre-clinical Animal Models | 83 | PR Newswire | |
| GAITHERSBURG, Md., Dec. 17, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ:GNVC) announced today that data were presented on its HSV vaccine program at the Keystone Symposia meeting on Immunological Mechanisms... Mehr lesen zu: Single Administration of GenVec's Vaccine Provides Protective Immunity Against HSV in Pre-clinical Animal Models | ||||
| 14.11. | Promising Data Presented on GenVec Malaria Program | 87 | PR Newswire | |
| GAITHERSBURG, Md., Nov. 14, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) announced today that data were presented on GenVec's malaria vaccine program at the American Society of Tropical Medicine... Mehr lesen zu: Promising Data Presented on GenVec Malaria Program | ||||
| 09.11. | GenVec Reports Third Quarter 2012 Financial Results | 34 | PR Newswire | |
| GAITHERSBURG, Md., Nov. 9, 2012 /PRNewswire/ --Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the three months and nine months ended September 30, 2012.
GenVec reported a net... Mehr lesen zu: GenVec Reports Third Quarter 2012 Financial Results | ||||
| 02.11. | GenVec To Release Third Quarter 2012 Financial Results And Conduct A Conference Call On November 9, 2012 | 49 | PR Newswire | |
| GAITHERSBURG, Md., Nov. 2, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) will report financial results for the third quarter ended September 30, 2012 on Friday, November 9, 2012, before the U.S.... Mehr lesen zu: GenVec To Release Third Quarter 2012 Financial Results And Conduct A Conference Call On November 9, 2012 | ||||
| 02.10. | GenVec Enters Into $3.5 Million Contract With Naval Medical Research Center To Advance Malaria Program | 49 | PR Newswire | |
| GAITHERSBURG, Md., Oct. 2, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) announced today that it has signed an agreement worth approximately $3.5 million with the Naval Medical Research Center (NMRC)... Mehr lesen zu: GenVec Enters Into $3.5 Million Contract With Naval Medical Research Center To Advance Malaria Program | ||||
| 01.10. | Promising Data Presented on GenVec RSV Program | 33 | PR Newswire | |
| GAITHERSBURG, Md., Oct. 1, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) announced today that data were presented on GenVec's respiratory syncytial virus (RSV) vaccine program at the "8th Annual... Mehr lesen zu: Promising Data Presented on GenVec RSV Program | ||||
| 25.09. | GenVec Announces Reduction in Workforce | 40 | PR Newswire | |
| GAITHERSBURG, Md., Sept. 25, 2012 /PRNewswire/ --GenVec, Inc. (Nasdaq: GNVC) announced today that it is lowering its operating costs to conserve capital including eliminating 23 positions, or approximately... Mehr lesen zu: GenVec Announces Reduction in Workforce | ||||
| 09.08. | GenVec Reports Second Quarter 2012 Financial Results | 168 | PR Newswire | |
| GAITHERSBURG, Md., Aug. 9, 2012 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the three months and six months ended June 30, 2012.
GenVec reported a net loss... Mehr lesen zu: GenVec Reports Second Quarter 2012 Financial Results | ||||
| 02.08. | GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012 | 27 | PR Newswire | |
| GAITHERSBURG, Md., Aug. 2, 2012 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) will report financial results for the second quarter ended June 30, 2012 on Thursday, August 9, 2012, before the U.S. financial... Mehr lesen zu: GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012 | ||||
| 07.06. | GenVec Announces Conditional Approval of FMD Vaccine for Cattle | 43 | PR Newswire | |
| GAITHERSBURG, Md., June 7, 2012 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) has issued... Mehr lesen zu: GenVec Announces Conditional Approval of FMD Vaccine for Cattle | ||||
| 25.05. | GenVec Reports Inducement Award | 172 | PR Newswire | |
| GAITHERSBURG, Md., May 25, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC) announced today that on May 23, 2012 it granted an option to purchase shares of its common stock to Cynthia... Mehr lesen zu: GenVec Reports Inducement Award | ||||
| 21.05. | GenVec Appoints Cynthia Collins as President and CEO | 29 | PR Newswire | |
| GAITHERSBURG, Md., May 21, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC)today announced that effective May 23, 2012 Cynthia Collins has been appointed as President and Chief Executive Officer. In... Mehr lesen zu: GenVec Appoints Cynthia Collins as President and CEO | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| EVOTEC | 2,81 | -0,28 % | Evotec: Kurs der Aktie hat weiteres Potenzial |
| CELL THERAPEUTICS | 0,94 | +6,09 % | Cell Therapeutics to Present at Upcoming Investor Conferences |
| VICAL | 2,759 | +0,25 % | Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma |
| GENEREX BIOTECHNOLOGY | 0,02 | 0 % | Generex Comments on Results of Stockholders' Meeting |
| MEDIGENE | 0,96 | +2,45 % | Medigene-Aktie feiert Studienergebnisse mit EndoTAG |
